Drug Shortage Report for CALCIUM GLUCONATE INJECTION, USP 10%
Report ID | 90052 |
Drug Identification Number | 02141019 |
Brand name | CALCIUM GLUCONATE INJECTION, USP 10% |
Common or Proper name | Calcium Gluconate |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | CALCIUM GLUCONATE |
Strength(s) | 94MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 50mL |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-07-26 |
Estimated end date | 2019-10-08 |
Actual end date | 2019-10-07 |
Shortage status | Resolved |
Updated date | 2020-01-16 |
Company comments | Product available |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-07-26 | English | Compare |
v2 | 2019-07-26 | English | Compare |
v3 | 2019-07-26 | French | Compare |
v4 | 2019-07-27 | English | Compare |
v5 | 2019-10-01 | English | Compare |
v6 | 2019-10-01 | French | Compare |
v7 | 2020-01-16 | English | Compare |
v8 | 2020-01-16 | French | Compare |
Showing 1 to 8 of 8